Hims & Hers Health HIMS
NYSE HIMS
$31.86 +0.77 (+2.48%)
At close: Aug 20, 2026 · 4:00 PM EDT

Hims & Hers Health (HIMS) Liabilities and Shareholders Equity (2019 - 2026)

Hims & Hers Health (HIMS) posted Liabilities and Shareholders Equity of $2.3 billion for Q1 2026, up 5.21% sequentially from $2.2 billion in Q4 2025, and up 154.24% YoY from $891.7 million in Q1 2025.

Hims & Hers Health (HIMS) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Hims & Hers Health has reported Liabilities and Shareholders Equity for 8 years, with the latest figure at $2.3 billion in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 154.24% year-over-year to $2.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 billion (up 218.14% YoY) and the FY2025 annual result came in at $2.2 billion, up 204.54% from the prior year.
  • Liabilities and Shareholders Equity advanced to $2.3 billion in Q1 2026 per HIMS's latest filing, from $2.2 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $2.3 billion in Q1 2026 and troughed at $366.3 million in Q4 2022.
  • A 5-year average of $870.3 million and a median of $448.1 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity dropped 12.9% in 2022, then surged 290.76% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $366.3 million in 2022, then increased by 20.43% to $441.2 million in 2023, then surged by 60.37% to $707.5 million in 2024, then soared by 204.54% to $2.2 billion in 2025, then climbed by 5.21% to $2.3 billion in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $2.3 billion, $2.2 billion, and $2.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 39.86 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 6.18 Bn
10 Hims & Hers Health 7.42 Bn 6.57 Bn 480.80 Mn 3.63 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.63 Bn
Mar 31, 2026 2.27 Bn
Dec 31, 2025 2.15 Bn
Sep 30, 2025 2.23 Bn
Jun 30, 2025 1.88 Bn
Mar 31, 2025 891.71 Mn
Dec 31, 2024 707.54 Mn
Sep 30, 2024 602.26 Mn
Jun 30, 2024 480.50 Mn
Mar 31, 2024 448.11 Mn
Dec 31, 2023 441.19 Mn
Sep 30, 2023 413.87 Mn
Jun 30, 2023 389.88 Mn
Mar 31, 2023 376.31 Mn
Dec 31, 2022 366.34 Mn
Sep 30, 2022 382.83 Mn
Jun 30, 2022 379.97 Mn
Mar 31, 2022 382.04 Mn
Dec 31, 2021 420.59 Mn
Sep 30, 2021 420.07 Mn